Lateral flow immunoassay (LFIA) combo test kit for rapid qualitative detection of carbapenem-resistant Enterobacteriaceae (CRE) strains carrying KPC, IMP, NDM, VIM, and OXA-48 resistance genes. Enables quick identification of antibiotic-resistant pathogens to guide appropriate antimicrobial therapy ...
Manufactured by
Nanjing, Jiangsu, China
Jiangsu Medomics Medical Technology Co., Ltd., founded in October 2017, is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments. Medomics owns two R D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 2,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions. At the very beginning of COVID-19 on early 2020, Medomics developed IgM/IgG antibody detecting kit with the team of Zhong Nanshang. And Medomics published the first research paper on international journal together with State Key Laboratory of Respiratory Disease (National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health). The detecting kit was validated by CDC, Harvard Medical School and Columbia University Irving Medical Center etc. Until May 2020, the kit has been exported to dozens of countries and areas, making great help against SARS-Cov-2. At present, Medomics s series products of SARS-Cov-2 detection have been developed according to ISO 13485 Quality System and European CE Certification.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
China · 2 relevant products
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 1 relevant product
CORIS BIOCONCEPT SRL
Belgium · 16 relevant products
CLONIT SRL
Italy · 1 relevant product
ZHUHAI DL BIOTECH CO.,LTD
China · 2 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 1 relevant product
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept
India · 2 relevant products
CHROMagar Microbiology
France · 1 relevant product
Hangzhou Genesis Biodetection & Biocontrol Co., Ltd.
China · 2 relevant products
AB ANALITICA Srl
Italy · 2 relevant products
63 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 107 closest product alternatives
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. · China
An IVDR-certified rapid molecular detection kit for identifying carbapenemase-producing organisms, including KPC, NDM, OXA-48, OXA-23, VIM, and IMP variants. This diagnostic test enables quick identification of carbapenem-resistant bacteria for antimicrobial stewardship and infection control. The kit provides rapid detection and classification of clinically significant carbapenemase types.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
High-sensitivity, high-specificity competitive binding immunoassays built on Lateral Flow Immunoassay (LFIA) technology for clinical, workplace, and point-of-care drug screening. Validated against GC/MS laboratory standards to deliver accurate, reliable results with minimized false positives. Available in customizable multi-panels up to 14-in-1 with read times under 5 minutes and custom cut-off levels available for OEM customers.
CORIS BIOCONCEPT SRL · Belgium
A lateral flow immunochromatographic diagnostic test for the rapid detection of multiple carbapenemases including KPC, NDM, VIM, IMP, and OXA-48-like enzymes in bacterial samples.
CLONIT SRL · Italy
Lateral flow assay (LFA) test kit for rapid detection of carbapenem-resistant Enterobacteriaceae in clinical samples. The test enables quick identification of antibiotic-resistant pathogens to support appropriate infection control and treatment decisions. Results are available within minutes of sample processing.
CORIS BIOCONCEPT SRL · Belgium
A lateral flow immunochromatographic diagnostic test for the rapid detection of KPC and NDM carbapenemases in bacterial samples.
CORIS BIOCONCEPT SRL · Belgium
A lateral flow immunochromatographic diagnostic test for the rapid detection of OXA-48-like carbapenemases in bacterial samples.
ZHUHAI DL BIOTECH CO.,LTD · China
Test for rapid detection of carbapenem-resistant bacteria including carbapenem-resistant Enterobacteriaceae. Identifies highly resistant pathogens.
CORIS BIOCONCEPT SRL · Belgium
A lateral flow immunochromatographic diagnostic test for the rapid detection of OXA-163-like and KPC carbapenemases in bacterial samples.
CORIS BIOCONCEPT SRL · Belgium
Rapid diagnostic kit for detecting carbapenemase-producing organisms in clinical samples. Delivers results quickly to enable timely infection control measures and antimicrobial stewardship decisions in routine laboratory settings.
CORIS BIOCONCEPT SRL · Belgium
Rapid diagnostic kit for detecting carbapenemase-producing organisms in clinical samples. Enables quick identification of antibiotic-resistant bacteria to support infection control measures and antimicrobial stewardship decisions in laboratory settings.
HLB PANAGENE Co., Ltd. · South Korea
A molecular diagnostic assay for detection of carbapenem-resistant Enterobacteriaceae in infectious disease diagnostics.
CORIS BIOCONCEPT SRL · Belgium
Rapid diagnostic test for detection of carbapenemase-producing organisms. Enables quick identification to support infection control measures and antimicrobial stewardship practices in clinical laboratories.
95 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products